ProHealth Urgent Care, a medical
facility serving patients in St. Croix, continues to take every initiative and
precaution during the COVID pandemic to care for the community safely.
ProHealth
received their allocated Pfizer-BioNTech COVID-19 vaccines at 8:00...
Today, the US Food and Drug Administration (FDA) advisory committee is holding a vote on whether to authorize Moderna's coronavirus vaccine in the United States. The approval, if provided today, would make the second coronavirus vaccine available in...
The Seattle Cancer Care Alliance (SCCA), the only National Comprehensive Cancer Network (NCCN)- member cancer center in Washington state, was selected by the Washington State Department of Health to be one of the first 17 sites to receive the...
A small Emeryville, CA biotech firm is developing InvisiMask, a self-administered nasal spray, that protects against SARS-CoV-2 infection, the novel coronavirus that causes COVID-19, for up to 10 hours in early animal studies. The hope would be to...
Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S.
The FDA...
Late day Thursday, a government advisory panel gave their nods for the use of Pfizer’s COVID-19 vaccine, allowing for the Food and Drug Administration (FDA) to grant the approval for the vaccine.
In a 17-4...
In a published study, in EBio Medicine, researchers at Arizona-based biotech, Aqualung Therapeutics may have identified a novel biomarker that alone, or potentially combined with Prostate-specific antigen (PSA), may determine men who are at higher risk of...
The US Food and Drug Administration on Friday evening granted Emergency Use Authorization for the first time to a diagnostic test for at-home, self-collection of patient samples for the detection of SARS-CoV-2 and influenza A/B.
According to new research published today in the American Heart Association's flagship journal Circulation, women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with...
Moderna today announced that the primary efficacy analysis of their Phase 3 study of their vaccine candidate, mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a...
Results from Zillow's Consumer Housing Trends Report show renters of color typically submit more applications — and pay more in application fees — before they secure...
A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody...
